Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Tyenne® (tocilizumab-aazg) – New biosimilar approval

March 6, 2024 - Fresenius Kabi announced the FDA approval of Tyenne (tocilizumab-aazg), biosimilar to Genentech’s Actemra (tocilizumab).

Download PDF

Rx navigation